Learning From China’s Experience Fighting Coronavirus
As Covid-19 disease reaches more countries and new reported cases continue to rise, public anxiety will increase and add more uncertainty for investors. Beyond efforts to contain the outbreak, we expect countries to intensify their fight against this highly contagious disease. We think significant insights can be gained by studying China’s experience in combating Covid-19.
The outbreak first started in China in December 2019. Following the government’s decisive actions, available data suggest that the coronavirus has now been largely contained. The economic and social costs of these measures are unfolding, but the actions have been effective.
Some observations from China’s experience with Covid-19 are:
Epidemic curve in China indicates successful containment
Commitment to contain the virus was directed by the highest level of leadership, which mobilized all available resources
Draconian actions, such as factory closures and mandatory quarantines, were taken at high costs
Fatality rates outside the Hubei Province are materially lower than inside it
China has provided measured, targeted stimulus as well as rate cuts to cushion the impact on small-and-medium enterprises and households; more stimulus measures are expected
Economy is coming back to life, gradually, as evidenced in various high frequency measures of economic activity
Key ongoing challenges for China are:
Containing imported cases
Preventing a flareup of virus cases as normal daily life returns
Implementing sufficient fiscal and monetary stimulus to ensure economic growth recovers, while at the same time not creating excessive and/or inefficient credit growth
Profound changes in consumer and business behaviors taking place during the outbreak may have lasting consequences. Social distancing has become a key operative word in the time of Covid-19, driving accelerated adoption of e-commerce, telecommuting and online entertainment. Also, the virus has increased awareness of the need for preventative health care as well as health and life insurance. The short-term negative impact on the global economy and capital markets could be significant. To eventually win this war, we need an effective treatment for and vaccine against the Covid-19 and this may take some time.
From an investment viewpoint, China looks to be in a better spot compared with most other countries. As the first country going into the war against Covid-19, China has managed through the initial surge phase of the outbreak and containment now looks achievable. The Chinese economy has taken a huge hit, but high-frequency economic activity data to date, such as coal consumption, suggests there is a gradual yet steady recovery in economic activity as the outbreak is contained.
In contrast, most other large economies are just beginning to recognize and take on the tough fight against Covid-19. The transient nature of the virus’ economic impact along with expectations of continued policy support may also be contributing to China’s outperformance in the MSCI Emerging Markets benchmark.
As active fundamental emerging market investors, we believe that excess returns above that of passive index can be achieved through a disciplined investment process that aims to identify long-term winners among all the listed companies.
There will be winners and losers among sectors and industries in the war against Covid-19. Among the losers we see travel & leisure, transportation and energy. Among winners are e-commerce, online entertainment and health care. Higher-quality companies with more resilient business models and stronger financial positions will likely emerge from this crisis in a better position to deliver returns for shareholders.
ETFs trade like stocks, are subject to investment risk, fluctuate in market value and may trade at prices above or below the ETFs net asset value. Brokerage commissions and ETF expenses will reduce returns.
SSGA SPDR ETFS MAY NOT BE AVAILABLE OR SUITABLE FOR YOU. THE VIEWS EXPRESSED/INFORMATION IN THIS SITE DO NOT CONSTITUTE INVESTMENT ADVICE, FINANCIAL, LEGAL, REGULATORY, ACCOUNTING OR TAX ADVICE. INDEPENDENT ADVICE SHOULD BE SOUGHT IN CASES OF DOUBT. NEITHER THE INFORMATION NOR ANY OPINION CONTAINED ON THIS SITE CONSTITUTES A SOLICITATION OR OFFER TO BUY OR SELL SHARES OF THE FUNDS OR ANY OTHER FINANCIAL INSTRUMENT.
Standard & Poor's®, S&P® and SPDR® are registered trademarks of Standard & Poor's Financial Services LLC (S&P); Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC (Dow Jones); and these trademarks have been licensed for use by S&P Dow Jones Indices LLC (SPDJI) and sublicensed for certain purposes by State Street Corporation. State Street Corporation's financial products are not sponsored, endorsed, sold or promoted by SPDJI, Dow Jones, S&P, their respective affiliates and third party licensors and none of such parties make any representation regarding the advisability of investing in such product(s) nor do they have any liability in relation thereto, including for any errors, omissions, or interruptions of any index.
SPDR ETFs may be offered and sold only in those jurisdictions where authorised, in compliance with applicable regulations.
Information related to Mexico
This information does not constitute and is not intended to constitute marketing or an offer of securities and accordingly should not be construed as such. The Funds referenced herein have not been, and will not be, registered under the Mexican Securities Market Law (Ley del Mercado de Valores) and may not be publicly offered or sold in the United Mexican States. Disclosure documentation related to any of the aforementioned Funds may not be distributed publicly in Mexico and shares of the Funds may not be traded in Mexico.
UCITS SPDR ETFs
SPDR ETFs Europe I Plc and SSGA SPDR ETFs Europe II Plc issue SPDR ETFs, and are an open-ended investment company with variable capital having segregated liability between its sub-funds. The Company is organised as an Undertaking for Collective Investments in Transferable Securities (UCITS) under the laws of Ireland and authorised as a UCITS by the Central Bank of Ireland.
This website is directed at Qualified Investors only, as defined by Article 10(3) and (3ter) of the Swiss Collective Investment Schemes Act (“CISA”) and its implementing ordinance. Certain funds may not be registered for public distribution with the Swiss Financial Market Supervisory Authority (FINMA), which acts as supervisory authority in investment fund matters, or may not have appointed a Swiss Representative and Paying Agent. For those funds which have appointed a Swiss Representative and Paying Agent, the prospectus, the articles of incorporation, the Key Investor Information Document (KIID) as well as the latest annual and semi-annual reports may be obtained free of charge from the Swiss Representative and Paying Agent, State Street Bank International GmbH, Munich, Zurich Branch, Beethovenstrasse 19, 8027 Zurich, or at www.ssga.com, as well as from the main distributor in Switzerland, State Street Global Advisors AG (“SSGA AG”), Beethovenstrasse 19, 8027 Zurich. For those funds which have not appointed a Swiss Representative and Paying Agent, please observe that the funds are open to Qualified Investors at the exclusion of Qualified Investors with an opting-out pursuant to Art. 5(1) of the Swiss Federal Law on Financial Services ("FinSA") and without any portfolio management or advisory relationship with a financial intermediary pursuant to Article 10(3ter) CISA (“Excluded Qualified Investors”). For further information and fund documents please contact SSGA AG.
You should obtain and read the SPDR prospectus and relevant Key Investor Information Document (KIID) prior to investing, which may be obtained by clicking here. These include further details relating to the SPDR funds, including information relating to costs, risks and where the funds are authorised for sale.
US SPDR ETFs
The distribution of interests of U.S. SPDR ETFs in Switzerland will be exclusively made to, and directed at, Qualified Investors only, as defined by Article 10(3) and (3ter) of the Swiss Collective Investment Schemes Act (“CISA”) and its implementing ordinance. Accordingly, U.S. SPDR ETFs are not registered for public distribution with the Swiss Financial Market Supervisory Authority ("FINMA"). Certain funds may not have appointed a Swiss Representative and Paying Agent. For those funds with a Swiss Representative and Paying Agent, the legal documents of the U.S. SPDR ETFs may be obtained free of charge from the Swiss Representative and Paying Agent, State Street Bank International GmbH, Munich, Zurich Branch, Beethovenstrasse 19, 8027 Zurich, or at www.ssga.com, as well as from the main distributor in Switzerland, State Street Global Advisors AG (“SSGA AG”), Beethovenstrasse 19, 8027 Zurich. For those funds without Swiss Representative and Paying Agent, please observe that the funds are open to Qualified Investors at the exclusion of Qualified Investors with an opting-out pursuant to Art. 5(1) of the Swiss Federal Law on Financial Services ("FinSA") and without any portfolio management or advisory relationship with a financial intermediary pursuant to Article 10(3ter) CISA (“Excluded Qualified Investors”). For further information and fund documents please contact SSGA AG.
Before investing, consider the funds' investment objectives, risks, charges and expenses. To obtain a prospectus which contains this and other information, download a prospectus here, or talk to your financial advisor. Read it carefully before investing.